Natera (NTRA) Free Cash Flow Growth (1y) (2015 - 2026)
Powered by 
Analysis
Natera (NTRA) Free Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -173.96% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 5.28% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | -42.16% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -5.46% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | -132.83% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 8.47% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 60.56% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 400.65% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 42.04% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 116.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -173.96% |
| Mar 31, 2026 | -20.33% |
| Dec 31, 2025 | 8.77% |
| Sep 30, 2025 | 4.25% |
| Jun 30, 2025 | 251.89% |
| Mar 31, 2025 | 238.57% |
| Dec 31, 2024 | 151.39% |
| Sep 30, 2024 | 191.77% |
| Jun 30, 2024 | 91.20% |
| Mar 31, 2024 | 107.23% |
| Dec 31, 2023 | 27.21% |
| Sep 30, 2023 | 66.23% |
| Jun 30, 2023 | 26.36% |
| Mar 31, 2023 | 39.61% |
| Dec 31, 2022 | 13.72% |
| Sep 30, 2022 | -9.85% |
| Jun 30, 2022 | -49.79% |
| Mar 31, 2022 | -79.90% |
| Dec 31, 2021 | -33.29% |
| Sep 30, 2021 | -197.09% |